AVITA Medical (AVHHL) Change in Receivables (2019 - 2025)

AVITA Medical has reported Change in Receivables for 7 years, with the latest figure at -$81000.0 in Q4 2025.

• For the quarter ending Q4 2025, Change in Receivables rose 94.56% year-over-year to -$81000.0; the trailing twelve-month figure through Dec 2025 stood at $3.6 million (up 187.65% YoY), and the FY2025 full-year result was $3.6 million, up 187.65% from the prior year.
• Change in Receivables for Q4 2025 stood at -$81000.0, down from $2.3 million in the prior quarter.
• The five-year high for Change in Receivables was $3.5 million in Q2 2021, with the low at -$3.5 million in Q4 2023.
• Historically, Change in Receivables has averaged -$130411.8 across 5 years, with a median of -$241000.0 in 2023.
• The largest YoY upside for Change in Receivables was 333.64% in 2021 against a maximum downside of 22320.0% in 2021.
• AVITA Medical's Change in Receivables stood at -$3.3 million in 2021, then jumped by 73.63% to -$879000.0 in 2022, then tumbled by 295.34% to -$3.5 million in 2023, then soared by 57.15% to -$1.5 million in 2024, then surged by 94.56% to -$81000.0 in 2025.
• The last three Change in Receivables figures came in at -$81000.0 (Q4 2025), $2.3 million (Q3 2025), and $1.6 million (Q2 2025), per Business Quant data.